Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019

Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019 Publisher

Safiri S^{1, 2} ; Nejadghaderi SA^{3, 4} ; Karamzad N⁵ ; Kaufman JS⁶ ; Carsonchahhoud K^{7, 8} ; Bragazzi NL⁹ ; Sullman MJM^{10, 11} ; Beyranvand MR⁴ ; Mansournia MA¹² ; Almasihashiani A¹³ ; Collins GS^{14, 15} ; Kolahi AA⁴

Show Affiliations

1. Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
2. Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
3. Systematic Review and Metaâ€�analysis Expert Group, SRMEG), Universal Scientific Education and Research Network (USERN, Tehran, Iran
4. Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5. Nutrition Research Center, Department of Biochemistry and Diet Therapy, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
6. Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, QC, Canada
7. Australian Centre for Precision Health, Allied Health and Human Performance, University of South Australia, Adelaide, SA, Australia
8. School of Medicine, The University of Adelaide, Adelaide, SA, Australia
9. Centre for Disease Modelling, York University, Toronto, ON, Canada
10. Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus
11. Department of Social Sciences, University of Nicosia, Nicosia, Cyprus
12. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
13. Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran
14. Centre for Statistics in Medicine, NDORMS, Botnar Research Centre, University of Oxford, Oxford, United Kingdom
15. NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Source: Frontiers in Endocrinology Published:2022

Abstract

Background: To report the burden of cancers attributable to high fasting plasma glucose (HFPG) by sex, age, location, cancer type and Socio-demographic Index (SDI) over the period 1990 to 2019 for 204 countries and territories. Methods: Using the Comparative Risk Assessment approach of Global Burden of Disease (GBD) study 2019, the burden of cancers attributable to HFPG was reported in 1990 and 2019. Results: Globally, in 2019 there were an estimated 419.3 thousand cancer deaths (95% UI: 115.7 to 848.5) and 8.6 million cancer DALYs (2.4 to 17.6) attributable to HFPG. By sex, 4.6 (1.1 to 9.9) and 4.0 (1.1 to 8.4) million global cancer DALYs were attributable to HFPG in men and women, respectively. The global age-standardized death and DALY rates of cancers attributable to HFPG (per 100,000) have increased by 27.8% (20.5 to 38.7%) and 24.5% (16.4 to 35.6%), respectively, since 1990. High-income North America (9.5 [2.7 to 18.8]) and Eastern Sub-Saharan Africa (2.0 [0.5 to 4.2]) had the highest and lowest regional age-standardized death rates, respectively, for cancers attributable to HFPG. In 2019, the global number of attributable cancer DALYs were highest in 65-69 age group. Moreover, there was an overall positive association between SDI and the regional age-standardized DALY rate for HFPG-attributable cancers. Conclusions: HFPG was associated with more burden in 2019. Preventive programs for diabetes and screening of individuals with diabetes for cancers, especially in older males living in developed countries, are required to arrest the large increases in HFPG-attributable cancers. Copyright © 2022 Safiri, Nejadghaderi, Karamzad, Kaufman, Carson-Chahhoud, Bragazzi, Sullman, Beyranvand, Mansournia, Almasi-Hashiani, Collins and Kolahi.

Related Docs

View other Related Docs

1. Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019, Cancer Medicine (2023)

2. Diabetes Risk and Provision of Diabetes Prevention Activities in 44 Low-Income and Middle-Income Countries: A Cross-Sectional Analysis of Nationally Representative, Individual-Level Survey Data, The Lancet Global Health (2023)

3. Impact of Diabetes Mellitus on Epithelial Ovarian Cancer Survival, BMC Cancer (2018)

4. Dietary Acid Load and Risk of Type 2 Diabetes Mellitus: A Case–Control Study, Clinical Nutrition ESPEN (2022)

5. Ultra-Processed Food Consumption and Adult Diabetes Risk: A Systematic Review and Dose-Response Meta-Analysis, Nutrients (2021)

6. Quality and Cost of Healthcare Services in Patients With Diabetes in Iran: Results of a Nationwide Short-Term Longitudinal Survey, Frontiers in Endocrinology (2023)

7. Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys, BMC Public Health (2022)

8. Comparative Efficacy and Safety of Probiotics, Prebiotics, and Synbiotics for Type 2 Diabetes Management: A Systematic Review and Network Meta-Analysis, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2024)

Experts (# of related papers)

View all Related Experts

Bagher Larijani (3)

Sakineh Shab-Bidar (3)

Style	Citing Format
MLA	Safiri S, et al.. "Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019." Frontiers in Endocrinology, vol. 13, no. , 2022, pp. -.
APA	Safiri S, Nejadghaderi SA, Karamzad N, Kaufman JS, Carsonchahhoud K, Bragazzi NL, Sullman MJM, Beyranvand MR, Mansournia MA, Almasihashiani A, Collins GS, Kolahi AA (2022). Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019. Frontiers in Endocrinology, 13(), -.
Chicago	Safiri S, Nejadghaderi SA, Karamzad N, Kaufman JS, Carsonchahhoud K, Bragazzi NL, Sullman MJM, et al.. "Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019." Frontiers in Endocrinology 13, no. (2022): -.
Harvard	Safiri S et al. (2022) 'Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019', Frontiers in Endocrinology, 13(), pp. -.
Vancouver	Safiri S, Nejadghaderi SA, Karamzad N, Kaufman JS, Carsonchahhoud K, Bragazzi NL, et al.. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019. Frontiers in Endocrinology. 2022;13():-.
BibTex	@article{ author = {Safiri S and Nejadghaderi SA and Karamzad N and Kaufman JS and Carsonchahhoud K and Bragazzi NL and Sullman MJM and Beyranvand MR and Mansournia MA and Almasihashiani A and Collins GS and Kolahi AA}, title = {Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019}, journal = {Frontiers in Endocrinology}, volume = {13}, number = {}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Safiri S AU - Nejadghaderi SA AU - Karamzad N AU - Kaufman JS AU - Carsonchahhoud K AU - Bragazzi NL AU - Sullman MJM AU - Beyranvand MR AU - Mansournia MA AU - Almasihashiani A AU - Collins GS AU - Kolahi AA TI - Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019 JO - Frontiers in Endocrinology VL - 13 IS - SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract